Evaluating biomarkers for predicting outcomes in myocarditis patients
Official title: Risk Stratification Value of Biomarkers in Patients With Myocarditis (FORWARD): a National, Multicenter, Retrospective-prospective, Cohort Study
Run by First Affiliated Hospital Xi'an Jiaotong University · NCT06010199 · Data updated 2026-11-12
This study is trying to find out if certain biological markers can help predict how well patients with myocarditis will do over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 80 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | August 25, 2023 |
| Main results expected | July 31, 2030 |
| Study ends | August 31, 2030 |
| Registry record updated | July 12, 2024 |
| Trial ID | NCT06010199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed with myocarditis who are regularly followed up at a cardiovascular center.
✕Probably not a fit
Patients outside the age range of 3 to 80 years, pregnant or lactating women, or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect clinical data and biological specimens from patients diagnosed with myocarditis to develop a predictive model for their prognosis. It involves both retrospective and prospective data collection, utilizing advanced techniques such as genome sequencing, transcriptome sequencing, and metabolomics analysis. The goal is to enhance understanding of myocarditis and improve risk stratification for affected patients.
Why it matters
Potential benefit: If successful, this study could lead to better prognostic tools for myocarditis, allowing for more personalized treatment strategies.
How similar studies have gone: While there have been studies on myocarditis, the specific approach of using a comprehensive biomarker-based predictive model is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients should meet the diagnostic criteria for myocarditis * Patients who are regularly followed up at the corresponding cardiovascular center Exclusion Criteria: * Age \<3 years or \>80 years * Pregnant or lactating women * The patient refused to sign the informed consent and refused to participate in the study * None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent
Where it's running
-
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China Recruiting
Study contacts
- Principal investigator: Yang Yan — First Affiliated Hospital Xi'an Jiaotong University
- Study coordinator: Guoliang Li
- Email: liguoliang_med@163.com
- Phone: +8613759982523
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Cardiac MRI to See How the Heart Is Working
This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.
-
Routine versus provisional distal perfusion catheter placement during mechanical circulatory support
This study tests whether placing a distal perfusion catheter routinely or only provisionally improves limb outcomes in patients needing femoral artery support for mechanical circulatory support.
-
T1 mapping to characterize heart tissue in common heart diseases
This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.
-
Using a myocarditis panel to guide treatment in children
This will test whether using a combined viral genome, bacterial serology, and inflammation panel to guide treatment helps children under 18 with myocarditis who have arrhythmias or reduced heart function.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Assessing genetic testing's role in arrhythmic myocarditis
This study is testing how genetic testing can help people with myocarditis and heart rhythm problems by finding specific gene changes that might affect their condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.